MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) ; volume:17 ; number:1 ; day:25 ; month:1 ; year:2022 ; pages:1-10 ; date:12.2022
Radiation oncology ; 17, Heft 1 (25.1.2022), 1-10, 12.2022
- Urheber
-
Pavic, Matea
Niyazi, M.
Wilke, L.
Corradini, S.
Vornhülz, M.
Mansmann, U.
Al Tawil, A.
Fritsch, R.
Hörner-Rieber, J.
Debus, Jürgen
Guckenberger, M.
Belka, C.
Mayerle, J.
Beyer, G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-022-01988-6
- URN
-
urn:nbn:de:101:1-2022050519132755344164
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pavic, Matea
- Niyazi, M.
- Wilke, L.
- Corradini, S.
- Vornhülz, M.
- Mansmann, U.
- Al Tawil, A.
- Fritsch, R.
- Hörner-Rieber, J.
- Debus, Jürgen
- Guckenberger, M.
- Belka, C.
- Mayerle, J.
- Beyer, G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma
MR-guided stereotactic body radiation therapy for primary cardiac sarcomas
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma
MR-guided stereotactic body radiation therapy for primary cardiac sarcomas
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma
MR-guided stereotactic body radiation therapy for primary cardiac sarcomas
Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer